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The lipid transporters of the phosphatidylinositol
transfer protein (PITP) family dictate phosphoinosi-
tide compartmentalization, and specific phosphoi-
nositides play crucial roles in signaling cascades,
membrane traffic, ion channel regulation, and actin
dynamics. Although PITPs are enriched in the brain,
their physiological functions in neuronal signaling
pathways in vivo remain ill defined. We describe
a CRISPR/Cas9-generated zebrafish mutant in a
brain-specific, conserved class II PITP member,
pitpnc1a. Zebrafish pitpnc1a mutants are healthy
but display widespread aberrant neuronal activity
and increased wakefulness across the day-night
cycle. The loss of Pitpnc1a increases insulin-like
growth factor (IGF) signaling in the brain, and inhibi-
tion of IGF pathways is sufficient to rescue both
neuronal and behavioral hyperactivity in pitpnc1a
mutants. We propose that Pitpnc1a-expressing neu-
rons alter behavior viamodification of neuro-modula-
tory IGF that acts on downstream wake-promoting
circuits.INTRODUCTION
Lipids are essential signaling molecules, with tight controls
governing their levels and subcellular compartmentalization.
One class of proteins with major roles in lipid regulation are the
phosphatidylinositol transfer proteins (PITPs). PITPs bind and
transfer phosphatidylinositol (PI), thereby regulating the levels
of phosphoinositides, including PI(4,5)bisphosphate. PITPs
have been especially implicated in neuronal lipid regulation
to alter functions ranging from phototransduction to neurite
outgrowth (Cockcroft, 2012). However, the diversity of PITPs
means much is yet to be discovered about critical functions of
PITPs in the brain.
The function of PITPNC1 in neurons has not been examined
as extensively as it has for other PITP family members, such as
RdgBa and PITPa. PITPNC1 has two isoforms generated viaCell R
This is an open access article undalternative splicing: the long variant PITPNC1-sp1 and the short
variant PITPNC1-sp2 (Takano et al., 2003). These isoforms likely
have distinct biochemical and functional properties, because
only PITPNC1-sp1 can bind 14-3-3 proteins (Garner et al.,
2011), and they are expressed in distinct regions of the embry-
onic mammalian brain (Takano et al., 2003). PITPNC1 has also
been implicated in breast cancer cell metastasis: PITPNC1
expression is a key target of the metastasis-suppressing micro-
RNA, miR-126 (Png et al., 2011); up to 46% of breast cancer tu-
mors show amplified PITPNC1 expression; and an interaction
between PITPNC1 and RAB1B at the Golgi was shown to drive
malignant secretion of molecules that promote metastasis
(Halberg et al., 2016). How PITPNC1’s role in pathogenic breast
cancer relates to its endogenous function remains unknown.
To identify PITPNC1’s physiological function in vivo, we used
CRISPR/Cas9 to create a zebrafish null mutant of a brain-spe-
cific ortholog of the human long isoform pitpnc1a. We find that
pitpnc1a mutants have widespread, elevated neuronal activity
and increased wakefulness across the 24 hr day-night cycle.
Because insulin-like growth factor (IGF) signaling is upregulated
in pitpnc1a mutants and inhibition of this pathway restores
mutant behavior, we propose that Pitpnc1a modulates IGF
signaling cascades to control the set point of neuronal
excitability.RESULTS
A Zebrafish Pitpnc1 Ortholog Binds PI and PA
To find zebrafish pitpnc1, we used the long human splice
variant PITPNC1-sp1 (NP_036549.2) in zebrafish genome data-
base queries (release GRCz10). Basic Local Alignment Search
Tool – Protein (BLASTP) searches and expressed sequence
tag (EST) alignments identified two zebrafish orthologs on chro-
mosome 3 (renamed pitpnc1a), and chromosome 16 (renamed
pitpnc1b) (Figure 1A; Figure S1A). The zebrafish pitpnc1a gene
is predicted to encode a 331 amino acid protein that shows
81% identity (90% similarity) with the human long splice variant
PITPNC1-sp1 (Figure S1B), while pitpnc1b encodes a shorter
305 amino acid protein similar to human PITPNC1-sp2 and
only 57% identity (71% similarity) to human PITPNC1-sp1 (Fig-
ure S1B). Both zebrafish proteins contain the PITP family, inositol
ring-coordinating amino acids (T59, K61, E86, and N90) (Tilleyeports 24, 1389–1396, August 7, 2018 ª 2018 The Author(s). 1389
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Figure 1. One Zebrafish PITPNC1 Ortholog Is Exclusively Expressed
in the Brain
(A) Zebrafish PITPNC1 orthologs and human splice variants.
(B–D0) pitpnc1amRNA is detected in the nervous system at 24 hpf (B and B0),
48 hpf (C and C0), and is widespread in the brain by 5 dpf (D and D0).
(E–G0 ) pitpnc1b mRNA is expressed in non-neuronal tissue, including the
pharyngeal arches and olfactory pits (E–F0). pitpnc1bmRNA is undetectable in
the larval brain (G and G0).
(H) pitpnc1a mRNA is expressed in many areas of the adult zebrafish brain.
(I) Pitpnc1a protein is detected only in the adult zebrafish brain. Transfected
HEK293 cells are a positive control.
Tel, telencephalon; TeO, optic tectum; Hyp, hypothalamus; Hb, hindbrain;
Hab, habenula; Cb, cerebellum. Scale bars, 100 mm (B–G0) and 500 mm (H).et al., 2004), but only Pitpnc1a retains potential 14-3-3 binding
serine residues (Figure 1A; Figure S1B).
Using purified His- and FLAG-tagged Pitpnc1a protein, we
tested whether zebrafish Pitpnc1a has biochemical properties
similar to those of the human protein. Pitpnc1a-His was able
to transfer both PI and PA (phosphatidic acid) in vitro at levels
comparable to the human PITPNC1-sp1 isoform (Figures S2A1390 Cell Reports 24, 1389–1396, August 7, 2018and S2B). Immunoprecipitation of transfected, FLAG-tagged
versions from Cos-7 cell lysates and probing for 14-3-3 proteins
on a western blot revealed that both the human PITPNC1-sp1
and the zebrafish Pitpnc1a bound 14-3-3 proteins, whereas
zebrafish Pitpnc1b did not (Figures S2C and S2D). Altogether,
these data indicate that the zebrafish Pitpnc1a is capable of
transferring both PI and PA and binding 14-3-3, similar to the
human PITPNC1-sp1 protein.
pitpnc1a Is Expressed in the Larval and Adult Zebrafish
Brain
PITPNC1-sp1 has been detected in the adult mouse heart and
brain, with specific enrichment in the dentate gyrus, thalamus,
and Purkinje layer of the cerebellum (Garner et al., 2011; Takano
et al., 2003). In zebrafish, we detected pitpnc1a transcripts by
in situ hybridization (ISH) in several regions of the developing
CNS by 24 hr post fertilization (hpf), including the dorsal fore-
brain, midbrain, and bilateral clusters of cells in the spinal
cord (Figures 1B and 1B0). At 48 hpf, pitpnc1a expresses highly
in the developing forebrain, midbrain, hypothalamus, and hind-
brain (Figures 1C and 1C0). By larval stages (5 days post fertiliza-
tion [dpf]), pitpnc1a expression is exclusively and extensively
detected throughout the brain, with particularly strong expres-
sion in the dorsal telencephalon (Figures 1D and 1D0). pitpnc1a
mRNA is also detectable in these areas in the adult zebrafish
brain, with strong expression in the forebrain, habenula, and
cerebellum, as well as expression in the optic tectum and
several hypothalamic and hindbrain nuclei (Figure 1H). We
did not detect pitpnc1a transcripts in the heart or other non-
neuronal tissues. In contrast, pitpnc1b transcripts were
excluded from the CNS at all stages, with the exception of
some expression at 24 hpf around the developing brain ventri-
cles that subsequently is undetectable (Figures 1E–1G0).
Expression of pitpnc1b is localized to the pharyngeal arches
and olfactory vesicles by 48 hpf (Figures 1F and 1F0), as well
as in the pronephric duct (data not shown). At 5 dpf, there are
no detectable pitpnc1b transcripts in the brain (Figures 1G
and 1G0). The distinct tissue distribution of pitpnc1a and
pitpnc1b supports the hypothesis that these genes have non-
overlapping functions in vivo.
To detect Pitpnc1a protein, we developed a polyclonal anti-
body against the unique C terminus of zebrafish Pitpnc1a that
shows no cross-reactivity with Pitpnc1b (Figure S2E). Western
blot analysis detected Pitpnc1a protein only in the adult zebra-
fish brain, with no detectable protein in heart, liver, eye, skin,
or muscle (Figure 1I). For comparison, a cross-reacting antibody
against human PITPNC1-sp1 detects PITPNC1-sp1 protein in
the adult rat heart and brain (Figure S2F). The restricted expres-
sion of Pitpnc1a allows functions of vertebrate PITPNC1 in the
brain to be experimentally isolated in vivo.
Zebrafish pitpnc1a Null Mutants Display Behavioral
Hyperactivity
To knock out Pitpnc1a function, we used CRISPR/Cas9 to intro-
duce a 5-base pair deletion into exon 2 of pitpnc1a (Figure 2A)
that is easily detected by high-resolution melt curve analysis
(Figure S3C). This deletion introduces a frameshift to make a
predicted truncated protein that lacks two key inositol binding
5’ – CAACAAGCTGCCCAGCTGGGCGCGAGCCGTGGTGCCC – 3’
5’ – CAACAAGCTGCCCA - - - - -GCGCGAGCCGTGGTGCCC– 3’
pitpnc1a +
piptnc1a d5
12
11
10
9
8
7
6
5
60
50
40
30
20
10
Day 6 Night 6
0 hr 14 hr 24 hr
Av
er
ag
e 
A
ct
iv
ity
 (s
ec
on
ds
/1
0 
m
in
ut
es
)
pitpnc1a +/+   N=103
pitpnc1a +/-    N=269 
pitpnc1a -/-    N=114
14                16                18                20                22               24
Av
er
ag
e 
A
ct
iv
ity
 (s
ec
on
ds
/1
0 
m
in
ut
es
)
Zeitgeber Time (hr)
60
50
40
30
20
10
  0
10
9
8
7
6
5
  0
4
3
2
1
p<0.001
p<0.05
p<0.01
p<0.001
Day
Night
0.45
0.40
0.35
0.30
0.25
0.20
0.15
0.10
0.05
     0
Tw
itc
he
s/
M
in
ut
e
pitpnc1a +/+
     N=30
pitpnc1a -/-
    N=30
Genotype 36 hpf 52 hpf incross 52 hpf
wild type 29.4 (20/68) 34.2 (65/190) 36.6 (15/41)
pitpnc1a -/- 53.4 (61/113) 51.3 (119/232) 66.7 (16/24)
Diﬀerence (+ cI) 24 (8.4-38.0) 17.1 (7.3-26.5) 30.1 (2.6-53.0)
Chi-squared 9.851 12.4 5.4
p-value 0.0002 0.0004 0.02
% Response
+/+ +/- -/-
Pitpnc1a
(PAb:520)
55 KDa
37 KDa GAPDH
pitpnc1a
p=0.02
Crispr/Cas9 targetPAM
A B
C D
C’ E
F G
Figure 2. pitpnc1a/ Larvae Are Behavior-
ally Hyperactive
(A) CRISPR/Cas9 generated a 5-base pair deletion
in exon 2 of pitpnc1a.
(B) Pitpnc1a protein is detected in pitpnc1a+/+
brain lysates, weaker in pitpnc1a+/, and unde-
tectable in pitpnc1a/.
(C) An activity plot across a 14:10 hr day-
night cycle (zoomed in C0) reveals hyperactivity
in 6 dpf pitpnc1a/. The shaded ribbons
represent ± SEM.
(D and E) Bar plots (±SEM) of the mean day (D)
and night (E) activity. pitpnc1a/ animals are
significantly more active during both day and night
(one-way ANOVA, Tukey’s post hoc test).
(F) At 36 hpf, pitpnc1a/ embryos twitch signifi-
cantly more than pitpnc1a+/+ (mean ± SEM, one-
way ANOVA).
(G) At both 36 and 52 hpf, pitpnc1a/ embryos are
significantly more touch sensitive (pooled data
from 5 and 4 independent experiments, respec-
tively, and repeated in a blinded pitpnc1a+/ in-
cross; chi-square test).residues (N90 and E86) (Figures S3A and S3B). Homozygous
mutant pitpnc1aD5/D5 adult brains lack detectable Pitpnc1a pro-
tein by western blot (Figure 2B), indicating the D5 pitpnc1a allele
is likely functionally null, and mutants will hereafter be called
pitpnc1a/.
Larval and adult homozygous pitpnc1a/ mutants appear
visually indistinguishable from wild-type siblings and are viable
and fertile, and the D5 allele is inherited in Mendelian ratios
(e.g., Figure 2C). Expression analysis of dorsal forebrain
(egr3, tbr1a, and eomesa) and hypothalamic (npvf) markers
found no changes in pitpnc1a/ larvae, suggesting that
Pitpnc1a is not required for the specification or differentiation
of these areas that strongly express pitpnc1a (Figures S3D
and S3E).
Because Pitpnc1a is exclusively detected in the zebrafish
brain, including areas that have been implicated in larval sleep
and arousal (Barlow and Rihel, 2017), we asked whether
behavior might be affected in pitpnc1a/ larvae by video-Cell Retracking them for several days (Rihel
et al., 2010). Mutants showed a consis-
tent increase in waking activity across
a 14:10 hr light:dark cycle relative to
pitpnc1a+/+ and pitpnc1a+/ (Figures
2C–2E). Larval sleep during the day was
also mildly reduced in both pitpnc1a+/
and pitpnc1a/ larvae (Table S1).
Because expression of pitpnc1a was
detectable by 24 hpf, we also tested
whether early embryonic behaviors were
affected. Mutant embryos spontaneously
coiled (i.e., twitched) significantly more
often than wild-type controls at 36 hpf
(Figure 2F) and were significantly more
touch sensitive at both 36 and 52 hpf
(Figure 2G). These results suggest thatPitpnc1a modulates the sensitivity of neurons involved in both
stimulus-evoked and spontaneous behaviors.
pitpnc1a/ Mutants Have Increased Neuronal Activity
in Arousal-Related Circuits
To map changes in neuronal activity that might underlie the
mutant behavior, we raised zebrafish in constant darkness
through 6 dpf, conditions that result in low expression of the
immediate early gene, c-fos, in wild-type larvae (Figures 3B
and 3B0). In contrast to dark-reared wild-type larvae, which
have barely detectable c-fos expression, pitpnc1a/ mutants
exhibited strong and extensive c-fos expression (Figures 3A
and 3A0). The c-fos expression was particularly strong in a broad
swath of the dorsal forebrain, two bilateral clusters in the ventral
forebrain, the preoptic area, the midbrain, the posterior hypo-
thalamus, and a bilateral cluster of neurons in the cerebellum
(Figures 3A and 3A0). To determine whether these populations
are similarly engaged during acute arousal, we exposed larvaeports 24, 1389–1396, August 7, 2018 1391
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Figure 3. pitpnc1a/ Brains Have
Increased Neuronal Activity
(A–B0) ISH reveals many areas of c-fos expression
in 6 dpf pitpnc1a/ larval brains (A and A0)
compared with wild-type (B and B0).
(C–D0) Following a 1 hr light pulse, additional neu-
rons express c-fos in pitpnc1a/ (C and C0) and
wild-type (D and D0). Many areas expressing c-fos
in wild-type after a light pulse overlap with strong
c-fos signals in pitpnc1a/ brains at 0 hr (black
arrowheads, D and D0).
(E–F0) After 2 hr of light, c-fos levels remain
elevated in pitpnc1a/ brains (E and E0 ) but have
returned to baseline in wild-type (F and F0).
(G) pERK/tERK comparison of dark-reared, 6 dpf
pitpnc1a/ (n = 15) and wild-type (n = 12) brains
reveals mutant brain areas with upregulated
(green) and downregulated (magenta) expression
of pERK relative to controls. White arrowheads
indicate areas of agreement between pERK and c-
fos expression, and white arrows show the down-
regulated signal. Data are shown as a thresholded
maximum projection overlaid on a maximum pro-
jection of the Z-Brain tERK reference (gray).
(H) Clustering the behavioral fingerprint of
pitpnc1a/ against 550 drug-induced behavioral
profiles places the phenotype in a strong day-
active and modestly night-active cluster (red
branches).
(I) Flumethasone increases the behavioral activity
of both wild-type and pitpnc1a/ to the same
level. DMSO-treated pitpnc1a/ animals are hy-
peractive (*p < 0.05, one-way ANOVA, Tukey’s
post hoc test). Both 10 and 30 mM flumethasone
increase larval activity (**p < 0.01, two-way
ANOVA, gene 3 dose, Tukey’s post hoc test).
(J) Flumethasone induces c-fos expression in
areas similar to pitpnc1a/ and light pulses (black
arrows).
Hb, hindbrain; POA, preoptic area. (A–F) Dorsal
view. (A0–F0) Lateral view. (J) Ventral view. Scale
bars, 100 mm.to a light pulse. Following 1 hr light exposure, wild-type brains
had increased c-fos expression in many areas that overlapped
with those regions upregulated in pipnc1a/ larvae in the
dark, including those in the dorsal and ventral forebrain,
midbrain, and posterior hypothalamus (black arrowheads, Fig-
ures 3D and 3D0). Additional circuits involved in the detection
and sensorimotor transformation of light also upregulated c-fos
expression, including the optic tectum and hindbrain (Figures
3C and 3D). This indicates that the baseline c-fos expression in
pitpnc1a mutants can be further elevated, at least in some neu-
rons. After 2 hr of light exposure, c-fos levels have returned to
near pre-pulse levels, with pitpnc1a/ maintaining higher
expression than wild-type (Figures 3E and 3E0). Thus, many
neuronal areas activated by light in wild-type are already active
in pitpnc1a/ larvae in the dark, which is consistent with the
increased mutant behavioral arousal during both day and night.
To complement the c-fos evidence, we used a measure of
neuronal activity based on changes in the ratio of phosphory-1392 Cell Reports 24, 1389–1396, August 7, 2018lated ERK (pERK) to total ERK (tERK), which has faster kinetics
relative to c-fos transcription (Randlett et al., 2015). Relative to
wild-type, pitpnc1a/ larvae have widespread neuronal activa-
tion, as detected by increased pERK/tERK ratio, with extensive
overlap with areas observed by c-fos, including the dorsal and
ventral forebrain, midbrain, and hypothalamus (Figure 3G; Fig-
ures S3F and S3G). However, pERK upregulation also extends
to areas not observed by c-fos expression, including the optic
tectum and hindbrain, which may reflect the faster kinetics or
higher sensitivity of pERK relative to c-fos. Morphing this data
onto the Z-Brain reference library identified brain regions and
neuronal subtypes that are most strongly enriched for upregu-
lated pERK activity in pitpcn1a/ brains (Table S2). This in-
cludes two dopaminergic populations of the diencephalon and
the hypocretin neurons of the anterior hypothalamus (Figure 3G),
which is consistent with an upregulation of known arousal
circuits in the diencephalon. Other upregulated areas overlap
with areas implicated in arousal, including the locus coeruleus
and dorsal raphe (Table S2). In contrast, few mutant brain areas
show a lower relative pERK signal (Figure 3G; Figures S3F and
S3G; Table S2).
Wake-Inducing Glucocorticoids Converge on Neurons
Activated in pitpnc1a Mutants
If pitpnc1a mutants are hyperactive due to dysregulation of
wake-promoting neurons, we speculated that wake-inducing
drugs would activate the same neuronal populations. To identify
likely drugs, we normalized the pitpnc1a/ behavioral parame-
ters to wild-type to generate a behavioral fingerprint (Rihel et al.,
2010), which was then hierarchically clustered against a dataset
of 550 drug-induced behaviors (Figure 3H). The pitpnc1a/
cluster was enriched with anti-inflammatory compounds
(46% of hits with a correlation coefficient > 0.7), including gluco-
corticoids (7 of the top 50), non-steroidal anti-inflammatory
drugs (NSAIDs; 3/50), and phosphodiesterase inhibitors (6/50)
(Table S3). This cluster is also enriched for NMDA antagonists
(7/50). Thus, the pitpnc1a/ behavioral arousal converges
onto drugs with shared biological properties that increase zebra-
fish wakefulness.
To test whether these drugs and the pitpnc1a mutation are
altering behavior via common or parallel pathways, we exam-
ined pitpnc1a mutant and wild-type responses to the glucocor-
ticoid flumethasone. As expected, flumethasone increased the
waking activity of wild-type animals (Figure 3I). However, flume-
thasone only increased the waking activity of pitpnc1a/ larvae
to the drug-treated wild-type level, indicating that pitpnc1a/
and flumethasone are non-additive and likely converge onto
common neuronal circuits. Consistent with this interpretation,
flumethasone upregulated c-fos expression in similar neuronal
populations that are upregulated in pitpnc1a/ animals
(Figure 3J).
IGFR Signaling Is Upregulated in pitpnc1a/ Brains
Because PITPNC1 enhances the secretion of pro-metastatic
factors and insulin growth factor binding protein 2 (IGFBP2)
(Halberg et al., 2016; Png et al., 2011), we tested whether IGF
signaling was altered in pitpnc1a/ brains. We used antibodies
against IGF-1 receptor beta phosphorylated at Y1135 (hereafter
called pIGFR) to detect activation of the IGF pathway. We
detected several pIGFR puncta in the dorsal telencephalon
of 6 dpf wild-type brain that were even more extensive in
pitpnc1a/ brains (Figures 4A and 4B). In the ventral hypothal-
amus, significantly fewer pIGFR puncta were detected in wild-
type brains compared to mutants (Figures 4C–4E). In contrast,
in the trunk and tail, which lack Pitpnc1a, pIGFR levels were un-
affected (Figures S4A and S4B). To confirm that these puncta
represent bona fide pIGFR, we soaked wild-type and mutant
larvae in IGFBP2, which abolished nearly all pIGFR puncta (Fig-
ure S4C). If IGF signaling is upregulated in the pitpnc1a/
brains, IGF should stimulate increased pitpnc1a/ brain growth
(Duan et al., 1999). We found that pitpnc1a mutants had a sig-
nificant increase in the ratio of intra-ocular brain width to body
length and a trend toward an increased brain length (Figures
S4E–S4G). Thus, piptnc1a mutants have increased insulin-like
growth factor receptor (IGFR) signaling and an increase in brain
growth.Inhibition of IGF Signaling Rescues pitpnc1a/
Neuronal Activity and Behavior
To test whether increased IGF signaling leads to altered mutant
behavior, we first soaked larvae overnight from 36 to 48 hpf in
1 ng/mL recombinant human IGFBP2 and assessed neuronal ac-
tivity by c-fos expression. Similar to 5 dpf brains, untreated
pitpnc1amutants had elevated c-fos levels, but overnight expo-
sure to IGFBP2 reduced mutant c-fos back to wild-type levels
(Figure 4F; Figure S4D).
We next tested whether inhibition of phosphatidylinositol 3-ki-
nase (PI3K) and Akt, components downstream of IGFR signaling,
could affect the aberrant neural and behavioral hyperactivity in
pitpnc1a mutants. Overnight (>16 hr) soaking of pitpnc1a/
larvae in either the PI3K inhibitor LY294002 (2 mM) or the allo-
steric Akt inhibitor MK-2206 (100 nM) rescued c-fos staining
from strong upregulation in mutants (Figures 4G and 4H) to
wild-type levels (Figures 4I and 4J). Soaking pitpnc1a/ larvae
in 1 mM MK-2206 also resulted in a reversion of the mutant
night-time hyperactivity to wild-type levels (Figure 4K), suggest-
ing that upregulated IGFR signaling in pitpnc1amutants leads to
aberrant neuronal and behavioral hyperactivity.
DISCUSSION
We found that the brain-specific, class II lipid transfer protein
Pitpnc1a is essential for maintaining proper neuronal activity
and wakefulness via modulation of IGF signaling. Our work not
only has implications for understanding the impact of phospho-
lipids on behavior but also may have clinical relevance, because
PITPNC1 is upregulated in many metastatic tumors (Halberg
et al., 2016) and polymorphisms in PITPNC1 have been linked
to type 2 diabetes mellitus (Greenawalt et al., 2012; Liu et al.,
2017).
Pitpnc1a Modulates Baseline Behavioral Activity
Zebrafish have two highly conserved and differentially ex-
pressed orthologs of the human PITPNC1 gene, pitpnc1a and
pitpnc1b, which correspond to the long and short human iso-
forms, respectively. Evolution often redistributes a protein’s
expression and function across duplicated genes, or ohnologs
(Pasquier et al., 2016), and this feature allowed us to isolate
the role of Pitpnc1 proteins in the brain by targeting zebrafish
pitpnc1a.
CRISPR/Cas9-generated pitpnc1a mutants are hyperactive
across the day:night cycle and exhibit increased neuronal activ-
ity as measured by both c-fos and pERK. Many of the neuronal
populations that are most strongly upregulated in pitpnc1a/
larvae overlap with neurons implicated in setting levels of zebra-
fish wakefulness, including arousing hypothalamic and hindbrain
populations. In addition, the non-additivity and neuronal conver-
gence between wake-promoting glucocorticoids and pitpnc1a
mutants indicates that neurons of the ascending arousal system
may act in concert to affect pitpnc1a mutant hyperactivity. The
human PITPNC1 gene resides within a copy number variant
associated with a syndromic intellectual disability caused by
loss of the neighboring gene PSMD12 (K€ury et al., 2017). Individ-
uals that have lost a larger region encompassing PITPNC1 often
exhibit hyperactivity.Cell Reports 24, 1389–1396, August 7, 2018 1393
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Figure 4. IGFR Signaling Is Enhanced in pitpnc1a/ Brains, and Inhibiting IGFR Signaling Rescues Neuronal and Behavioral Hyperactivity
(A–E) 6 dpf pitpnc1a/ larvae have increased pIGFR puncta in the brain. (A–B0 ) Confocal projections of the dorsal telencephalon in wild-type (A and A0) and
pitpnc1a/ (B andB0) reveal pIGFR puncta (green). Nuclei are DAPI stained (blue) in (A0) and (B0 ). Confocal projections of the pitpnc1a/ ventral hypothalamus (D
and D0) have more pIGFR puncta (C and C0 ), as quantified in (E) (mean ± SEM, one-way ANOVA).
(F) Upregulated c-fos in pitpnc1a/ embryos is reduced to wild-type by soaking in 1 ng/mL IGFBP2 from 36 to 48 hpf.
(G–J) ISH for c-fos in 6 dpf brains in constant dark after overnight exposure to PI3K (LY-294002, 2 mM) or Akt (MK-2206, 100 nM) inhibitors. (G and H) c-fos is
upregulated in pitpnc1a/ brains (G) relative toWT controls (H). (I and J) Akt (I) and PI3K (J) inhibitors reducemutant c-fos expression to wild-type levels. Brains in
(G)–(J) are overdeveloped to expose even weak c-fos expression.
(K) Exposure to 1 mMAkt inhibitor, MK-2206, reduces average night-time activity of 6 dpf pitpnc1a/ larvae to wild-type levels. Each dot represents a single larva,
and the crossbars plot the mean ± SEM (two-way ANOVA, genotype 3 drug interaction, Tukey’s post hoc test).
(L) Model of Pitpnc1a modulation of neuronal activity via IGFBP2 and inhibition of IGF-PI3K-Akt. Loss of Pitpnc1a enhances IGF signaling, leading to increased
waking behavior.
(G–J) Ventral view; scale bars, 100 mm. (A–B0) Scale bars, 100 mm. (C–E0) Scale bars, 20 mm.
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Pitpnc1a, IGF, and Neuronal Activity
The pitpnc1a mutants had increased activation of IGF
signaling, and blocking this cascade upstream with IGFBP2
or downstream with PI3K and Akt inhibitors was sufficient to
restore neuronal and behavioral activity. Taking this data
together with observations in the cancer literature, we propose
a model (Figure 4L) in which Pitpnc1a stimulates the secretion
of inhibitory IGFBP2 that acts as an IGF counterbalance onto
circuits involved in wakefulness. When Pitpnc1a is missing,
IGF signaling is too high, leading to PI3K-Akt activation,
upregulation of neuronal activity, and ultimately increased
wakefulness.
Altered PI3K-Akt signaling has been implicated in a variety of
neurodevelopmental and psychiatric diseases, including autism
(Chen et al., 2014) and schizophrenia (Zheng et al., 2012), but the
mechanisms by which this may affect neuronal circuits remains
obscure. In light of the data that Pitpnc1a modulates IGF-PI3K-
Akt signaling in the vertebrate brain, the role of lipid transporters
in the progression, mitigation, or exacerbation of these complex
mental disorders should be further investigated.
EXPERIMENTAL PROCEDURES
Zebrafish Strains
AB/TL zebrafish were maintained at 28.5C by the University College London
(UCL) Fish Facility. pitpnc1a/ animals were generated using CRISPR/
Cas9 and outcrossed back to AB/TL for at least 3 generations. Work was in
accordance with the Animal Experimental Procedure Act (1986) under license
70/7612.
CRISPR/Cas9 Targeting pitpnc1a and Genotyping
CRISPR/Cas9 targeting of pitpnc1a exon 2 was carried out as described
(Hwang et al., 2013), using the guide RNA sequence (50-ACCACGGCTC
GCGCCCAGCT-30), which was synthesized as a DNA template using GeneArt
Strings (Invitrogen) and then transcribed with a T7 RNA synthesis kit
(New England Biolabs). PCS2-Cas9 (Addgene 47322), a gift from Alex Schier,
was transcribed using a SP6 mMESSAGE mMACHINE kit (Ambion) and then
co-injected with the guide RNA (gRNA) into one-cell embryos. Genomic
DNA was Hotshot extracted from single 24 hpf embryos; 85 base pair flanking
the cut site were PCR amplified (forward: 50-TCTGTCCGTCTGCTCTCTTC-30;
reverse: 50-AGGCTTTCTCCGTCACGTAG-30) and subjected to high resolution
melt curve analysis (HRMA) using Precision Melt Supermix (Bio-Rad). Muta-
tions were confirmed by Sanger sequencing (Source Biosciences).
pERK/tERK Activity Mapping
Immunohistochemistry
Fish were fixed overnight at 4C in 4% paraformaldehyde (PFA) and 4%
sucrose in PBS; permeabilized 45 min in 0.05% trypsin-EDTA on ice; blocked
6 hr at room temperature (RT) in phosphate buffered saline plus 0.05% Triton
(PBT) plus 2% normal goat serum, 1% BSA, and 1% DMSO; and then
incubated over sequential nights at 4C in primary antibodies (Cell Signaling
Technology 4370 and 4696; 1:500) and secondary antibodies conjugated
with Alexa fluorophores (Life Technologies; 1:200) in PBT plus 1% BSA and
1% DMSO.
Imaging
Larvae were mounted in 1.5% low melt agarose and imaged with a custom
two-photon microscope (Bruker; Prairie View software) with a 203 water
immersion objective (Olympus).
Z-Brain Registration and Mapping
Images were noise filtered using a custom MATLAB (The MathWorks)
scripts and registered into Z-Brain using the Computational Morphometry
Toolkit (http://www.nitrc.org/projects/cmtk/) with the command string:
-a -w -r 0102 -l af -X 52 -C 8 -G 80 -R 3 -A "–accuracy 0.4 –auto-multi-levels4" -W "–accuracy 1.6" -T 4. Registered images were prepared using a custom
MATLAB/MIJ (http://bigwww.epfl.ch/sage/soft/mij/) script to downsize, blur,
and adjust the maximum brightness of each stack to the top 0.1% of pixel
intensities to preserve dynamic range. Activity maps were generated using
MATLAB scripts (Randlett et al., 2015).
Behavioral Analysis
Sleep and Wake
Larvae were raised on a 14:10 hr light:dark cycle at 28.5C. On 4 dpf, larvae
were singly placed into a clear 96-square well plate (Whatman) filled with
650 mL of fish water (0.3 g/L Instant Ocean and 1 mg/L methylene blue
[pH 7.0]). The plate was placed in a custom-modified Zebrabox (ViewPoint
Life Sciences), and each well was monitored by automated tracking software
and analyzed as in Rihel et al. (2010).
Spontaneous Coiling
Wild-type and mutant embryos from 30–36 hpf were kept in their chorion and
placed in rows of 10 under a dissecting microscope. Coils per embryo were
manually counted in three independent experiments.
Touch Sensitivity
36 and 52 hpf mutant and wild-type larvae were singly pipetted into a dish and
then touched on the tail or head with a bent pipet tip. A response was recorded
if the larva elicited an escape. One set was performed on larvae from a
pitpnc1a+/ in-cross followed by genotyping.
In Vivo Drug Experiments
Larvae were dark reared at 28.5C to 5 dpf and then exposed to the PI3K in-
hibitor LY294002 or the Akt inhibitor MK-2206 in 5 mL of water in six-well
plates (n = 25) overnight, anesthetized with MS-222, and fixed with 4% PFA.
For behavioral testing, drugs dissolved in DMSOwere added to each well (final
concentrations of 100 nM to 10 mM, 0.2% DMSO). Outliers (n = 1) were
excluded by Grubb’s test (p < 0.01). For IGFBP2 soaking, 10 dechorionated
34 hpf embryos were transferred into 100 mL of fish water with 0, 0.05, 0.1,
0.5, and 1 ng/mL of recombinant human IGFBP2 (PeproTech, Catalog no.
350-06B) in a 96-well plate overnight at 28.5C.
Statistical Analysis
Behavioral data were analyzed for statistical significance using one-way
ANOVA followed by Tukey’s post hoc test (a = 0.05). Interactions between ge-
notype and drug were analyzed by two-way ANOVA (a = 0.05). Touch sensi-
tivity was analyzed by chi-square test.
Molecular and Biochemical Methods
See Supplemental Information for additional information.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and three tables and can be found with this article online at
https://doi.org/10.1016/j.celrep.2018.07.012.
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